Nomura Holdings’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-19,209	Closed	-$785K	–	1417
2024 Q2	$785K	Sell	19,209 -16,981	-47%	-$694K	﹤0.01%	613
2024 Q1	$1.53M	Buy	36,190 +13,690	+61%	+$579K	﹤0.01%	448
2023 Q4	$954K	Buy	+22,500	New	+$954K	﹤0.01%	627